203 related articles for article (PubMed ID: 2206782)
1. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
Müller TH; Su CA; Weisenberger H; Brickl R; Nehmiz G; Eisert WG
Br J Clin Pharmacol; 1990 Aug; 30(2):179-86. PubMed ID: 2206782
[TBL] [Abstract][Full Text] [Related]
2. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction.
Müller TH
Neurology; 2001; 57(5 Suppl 2):S8-S11. PubMed ID: 11552048
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
Caplain H
Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
Heptinstall S; Fox S; Crawford J; Hawkins M
Thromb Res; 1986 Apr; 42(2):215-23. PubMed ID: 3715801
[TBL] [Abstract][Full Text] [Related]
6. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
Violi F; Praticò D; Iuliano L; Balsano F
J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
[TBL] [Abstract][Full Text] [Related]
7. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
Cadroy Y; Thalamas C; Sakariassen K; Boneu B
Thromb Res; 2005; 116(4):293-300. PubMed ID: 16038713
[TBL] [Abstract][Full Text] [Related]
8. [Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers].
Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; de Pablo Molina J; Sánchez de la Cuesta F
Med Clin (Barc); 1985 Nov; 85(18):743-5. PubMed ID: 4094486
[No Abstract] [Full Text] [Related]
9. Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination.
Escolar G; Bastida E; Ordinas A; Castillo R
Thromb Res; 1985 Nov; 40(3):419-24. PubMed ID: 4082117
[No Abstract] [Full Text] [Related]
10. Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood.
Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
Thromb Haemost; 1981 Apr; 45(2):136-41. PubMed ID: 7256696
[TBL] [Abstract][Full Text] [Related]
11. Effects of dipyridamole and low-dose aspirin therapy on platelet adhesion to vascular subendothelium.
Lauri D; Zanetti A; Dejana E; de Gaetano G
Am J Cardiol; 1986 Dec; 58(13):1261-4. PubMed ID: 3788816
[TBL] [Abstract][Full Text] [Related]
12. Does the association dipyridamole-aspirin only act by a functional synergism?
De la Cruz JP; Sanchez de la Cuesta F
Gen Pharmacol; 1991; 22(2):271-4. PubMed ID: 2055420
[TBL] [Abstract][Full Text] [Related]
13. [The effect of low-dose acetylsalicylic acid on platelet aggregation parameters in vitro].
Cardona M; Escolar G; Roig E; Bastida E; Ordinas A; Sanz G
Rev Esp Cardiol; 1992 Apr; 45(4):264-9. PubMed ID: 1598464
[TBL] [Abstract][Full Text] [Related]
14. [Effect of dipyridamole (225 mg/day) and acetylsalicylic acid (150 mg/day) on various platelet parameters in non-complicated diabetes mellitus].
Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; García Arnés J; de Pablo Molina J; Sánchez de la Cuesta F
Med Clin (Barc); 1986 May; 86(17):712-5. PubMed ID: 3736161
[No Abstract] [Full Text] [Related]
15. Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers. The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan).
Serebruany VL; Malinin AI; Hanley DF
Thromb Haemost; 2008 Jan; 99(1):116-20. PubMed ID: 18217142
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
McCollum CN; Crow MJ; Rajah SM; Kester RC
Surgery; 1980 Jun; 87(6):668-76. PubMed ID: 6445604
[TBL] [Abstract][Full Text] [Related]
17. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
Serebruany VL; Malinin AI; Sane DC
Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
[TBL] [Abstract][Full Text] [Related]
18. The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.
Rajah SM; Penny AF; Crow MJ; Pepper MD; Watson DA
Br J Clin Pharmacol; 1979 Nov; 8(5):483-9. PubMed ID: 508556
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.
Liu Y; Cone J; Le SN; Fong M; Tao L; Shoaf SE; Bricmont P; Czerwiec FS; Kambayashi J; Yoshitake M; Sun B
J Cardiovasc Pharmacol; 2004 Aug; 44(2):266-73. PubMed ID: 15243309
[TBL] [Abstract][Full Text] [Related]
20. Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole.
Sinzinger H; O'Grady J; Fitscha P
J Int Med Res; 1988; 16(1):39-43. PubMed ID: 3350203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
